We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Clarius Launches AI-Enabled Handheld Wireless Ultrasound Scanners Miniaturized to Size of iPhone

By HospiMedica International staff writers
Posted on 19 Jan 2022

Clarius Mobile Health (Vancouver, BC, Canada) has become the first company to introduce a third-generation product line of high-performance handheld wireless ultrasound scanners for all medical specialists. More...

Now 30% lighter and smaller, the new pocket-sized scanners are available with revolutionary pricing and new features that will put premium handheld ultrasound into the hands of more doctors. The entire Clarius HD3 line of ultra-portable scanners is built with the latest antenna technology for steadfast connectivity operating on both iOS and Android devices. Octal beamforming technology delivers up to eight times faster frame rates and micron-level resolution compared to other handhelds. The new Clarius scanners deliver the detailed image quality clinicians rely on to make an accurate diagnosis, treat patients with confidence, and safely guide procedures for consistent patient outcomes.

Clinicians across the medical spectrum can choose from 10 wireless ultrasound scanners that are operated by the Clarius Ultrasound App. A new version of the Clarius Ultrasound application is also being released to the App Store or Google Play store with new AI and imaging tools that further advance image quality, as well as new advanced clinical software packages and features that enable clinicians to personalize their imaging experience. Compatible with most iOS and Android smart devices, the new Clarius Ultrasound App 9 is now available for download to all new and existing Clarius users. The new Clarius scanners have been cleared by the US Food and Drug Administration and regulatory clearance in other regions is pending.

"The new Clarius HD3 is now so remarkably small that it's no bigger than my iPhone," said Clarius CEO Laurent Pelissier. "Our world-class R&D team has miniaturized the high-performance of traditional, cart-based ultrasound systems into a new form factor that truly feels like a traditional ultrasound probe. By replacing complex knobs and buttons with artificial intelligence (AI), it automatically optimizes imaging for ease of use."

"Designing with the best image quality is our core guiding principle, and we delivered with App 9," said Kris Dickie, Vice President of Research and Development at Clarius. "HD Zoom packs more pixels into a small area of focus, full-screen mode fully utilizes the entire mobile screen, while trapezoidal imaging expands the field of view."

Related Links:
Clarius Mobile Health 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gas Analyzer
GE SAM
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.